Senior Manager, Regional Access, Germany

revolutionmedicines; München; On-site; EUR 90,000 - 150,000; Full time

Job summary

Revolution Medicines is seeking a Regional Market Access lead in Germany to execute the national market access strategy, secure reimbursement, and coordinate with sales, medical, and policy teams to optimize patient access.

You will build relationships with health insurers, hospitals, and physicians associations, translate policy changes into launch plans, and support regional events to advance access for Revolution Medicines assets.

Qualifications

• Bachelor's degree required.
• 6+ years of experience in a Regional Market Access role within pharma/biopharma.
• Extensive experience with statutory health insurance companies in Germany and with physicians' associations, MDK, and other stakeholders.
• Deep knowledge of regulations in the German pharmaceutical healthcare system including pricing, post-AMNOG hurdles, and reimbursement frameworks.

Responsibilities

• Secure hospital pharmacy listings for assets once available in Germany.
• Identify market-specific needs of prescribers and healthcare stakeholders and develop tactics to address access barriers.
• Develop regional/local approaches within the market-access strategy to enable patient access.
• Establish and maintain a network with health insurers, physicians' associations, MDK, and policy makers.
• Serve as a primary contact for market access stakeholder groups including health insurers and hospital administrators.
• Monitor regulatory changes and translate insights into actionable recommendations for regional and national teams.

Education

Bachelor's degree

Advanced degree preferred

Job description

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients.

The Opportunity:

In this role you will drive the execution of regional and local market access priorities within the national market access strategy, identifying and prioritizing barriers to timely and sustainable patient access. The role will be responsible for providing hands-on support in executing key launch activities across Germany supporting country-level regional and local market access tactics and initiatives to secure reimbursement of Revolution Medicines' assets. In close cooperation with the sales, marketing, government affairs, and medical departments and in line with the overall commercial business strategy, you will have an instrumental role in the development and execution of market access solutions. This will involve detailed and strategic involvement of various internal and external stakeholders, including hospitals, office-based oncologists, pharmacies, health insurances as well as medical associations and policy makers.

Key Responsibilities:

• Secure listing in hospital pharmacy lists for Revolution Medicines' assets once available across Germany, identifying organizational hurdles that might hinder broad adaptation in existing treatment algorithms.
• Identify market specific needs of prescribers, pharmaceutical decision makers and health policy stakeholders and develop tactics to address evolving market access barriers.
• Identify access barriers and developing/recommending regional or local approaches and tactics within the established market-access strategy to enable patient-access. This may include e.g. named-patient access, if needed, complying with all relevant regulations for industry involvement.
• Establish and maintain a network amongst opinion leaders, health insurances, physicians' associations, and health policy makers.
• Serve as one of the primary contact points for various market access stakeholder groups, including health insurances (incl. MDK (\"Medizinischer Dienst\")), pharmacies, and hospital administrators.
• Monitor, collect and inform internal stakeholders with insights on emerging changes in the pharmaceutical policy, pricing, and market access reimbursement framework relevant in the context of Revolution Medicines' assets. Translate regional insights into actionable recommendations for the regional and national market access team to inform launch and lifecycle planning.
• Position and represent Revolution Medicines and its assets in the best possible way towards all relevant healthcare bodies and stakeholders in Germany.
• Jointly with the Regional Access team initiate and organize regional/local events and projects to support reimbursement activities. Provide internal and external explanations and training materials regarding market access topics for all relevant stakeholder groups.
• Partner with Sales, Medical and other relevant functions to address regional patient-access barriers, taking ownership of agreed access-related initiatives and providing expertise on reimbursement matters, including but not limited to: supportive argumentation on the value of the innovative character of Revolution Medicines assets, participating in discussions with German oncologists on reimbursement and market access topics, supporting initiatives around NUB applications for hospital use of Revolution Medicines assets in Germany.

Required Skills, Experience and Education:

Bachelor's degree required; advanced degree in Pharmacy, Health Economics, Public Health, Life Sciences, or Business preferred (e.g., PharmD, PhD, MBA).

6+ years of experience in a Regional Market Access role within the pharmaceutical or biopharma industry.

Extensive experience in working with statutory health insurance companies in Germany, as well as with physicians' associations, MDK (\"Medizinischer Dienst\"), and other stakeholders.

Extensive knowledge of existing regulations in the German pharmaceutical healthcare system, including but not limited to the legal pricing framework, post-AMNOG system-imminent access hurdles, dispensing of pharmaceuticals, the taxation and reimbursement framework, (re-) importation of pharmaceuticals, patient-individual importation of drugs, federal/regional contracts on dispensation of pharmaceuticals (e.g. dispensing